These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 19879523)

  • 21. Anti-D in Rh positive pregnancies.
    Prasad MR; Krugh D; Rossi KQ; O'Shaughnessy RW
    Am J Obstet Gynecol; 2006 Oct; 195(4):1158-62. PubMed ID: 17000249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Consequences of being Rhesus D immunized during pregnancy and how to optimize new prevention strategies.
    Tiblad E; Westgren M; Pasupathy D; Karlsson A; Wikman AT
    Acta Obstet Gynecol Scand; 2013 Sep; 92(9):1079-85. PubMed ID: 23750781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemolytic disease of newborn due to anti-Jk b in a woman with high risk pregnancy.
    Thakral B; Malhotra S; Saluja K; Kumar P; Marwaha N
    Transfus Apher Sci; 2010 Aug; 43(1):41-3. PubMed ID: 20558106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prenatal typing of Rh and Kell blood group system antigens: the edge of a watershed.
    van der Schoot CE; Tax GH; Rijnders RJ; de Haas M; Christiaens GC
    Transfus Med Rev; 2003 Jan; 17(1):31-44. PubMed ID: 12522770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of pregnancies complicated by anti-E alloimmunization.
    Joy SD; Rossi KQ; Krugh D; O'Shaughnessy RW
    Obstet Gynecol; 2005 Jan; 105(1):24-8. PubMed ID: 15625137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosing hemolytic disease of the newborn.
    Brantley TA
    Clin Lab Sci; 2002; 15(3):140-3. PubMed ID: 12778961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Current viewpoints in the anti-D prevention of rhesus alloimmunization in the pregnant woman and of hemolytic disease of the newborn infant (a review of the literature)].
    Spasova K; Vŭlcheva B
    Akush Ginekol (Sofiia); 1986; 25(3):84-90. PubMed ID: 3019168
    [No Abstract]   [Full Text] [Related]  

  • 28. Non-invasive fetal RHD and RHCE genotyping from maternal plasma in alloimmunized pregnancies.
    Hromadnikova I; Vesela K; Benesova B; Nekovarova K; Duskova D; Vlk R; Spalova I; Gerychova R; Hakenova A; Rosenbaumova Z; Vlasin P; Vlachova A; Palasek V; Roznakova E; Calda P
    Prenat Diagn; 2005 Dec; 25(12):1079-83. PubMed ID: 16231295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Decreasing Rhesus serum antibody titer in pregnancy with Rhesus constellation].
    Kölbl H; Riss P
    Geburtshilfe Frauenheilkd; 1987 Apr; 47(4):285-6. PubMed ID: 3110000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.
    Kumpel BM
    Transfusion; 2006 Sep; 46(9):1652-6. PubMed ID: 16965599
    [No Abstract]   [Full Text] [Related]  

  • 31. [Epidemiology of anti-D allo-immunization during pregnancy].
    Branger B; Winer N
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S87-1S92. PubMed ID: 16495833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Rh (D) alloimmunization and pregnancy. Analysis of the causes after prophylaxis introduction].
    Furundarena JR; Ibisate A; Burguete Y; González de Langarica E; González N; Urquiza R; Mendizabal A; Hernando N; Pérez Clausell C
    Sangre (Barc); 1999 Dec; 44(6):429-33. PubMed ID: 10822755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
    Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
    Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of Rh hemolytic disease of the newborn.
    Jennings ER; Dibbern HH; Hodell FH; Monroe CH; Peckham NH; Sullivan JF; Pollack W
    Calif Med; 1969 Feb; 110(2):130-3. PubMed ID: 4181977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Report of the first nationally implemented clinical routine screening for fetal RHD in D- pregnant women to ascertain the requirement for antenatal RhD prophylaxis.
    Clausen FB; Christiansen M; Steffensen R; Jørgensen S; Nielsen C; Jakobsen MA; Madsen RD; Jensen K; Krog GR; Rieneck K; Sprogøe U; Homburg KM; Grunnet N; Dziegiel MH
    Transfusion; 2012 Apr; 52(4):752-8. PubMed ID: 21995641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated anti-D titer after the administration of Rh immune globulin. A case report.
    Andres RL; Branch DW; Scott JR
    J Reprod Med; 1989 Apr; 34(4):318-20. PubMed ID: 2497253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RhD hemolytic disease of the newborn.
    Bowman JM
    N Engl J Med; 1998 Dec; 339(24):1775-7. PubMed ID: 9845715
    [No Abstract]   [Full Text] [Related]  

  • 38. Unexpected suppression of anti-Fya and prevention of hemolytic disease of the fetus and newborn after administration of Rh immune globulin.
    Branch DR; Scofield TL; Moulds JJ; Swanson JL
    Transfusion; 2011 Apr; 51(4):816-9. PubMed ID: 20946183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Twin pregnancy complicated by severe hemolytic disease of the fetus and newborn due to anti-g and anti-C.
    Trevett TN; Moise KJ
    Obstet Gynecol; 2005 Nov; 106(5 Pt 2):1178-80. PubMed ID: 16260562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of the fetal immune system in the pathogenesis of RhD-hemolytic disease of newborns.
    Gurevich P; Erina S; Gershon S; Zusman I
    Hum Antibodies; 1997; 8(2):76-89. PubMed ID: 9289392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.